Event Registration for Industry Professionals | Molecular Tumor Board: Integrating Biomarker Analyses into Clinical Decision-Making Regarding the Use of Immune Checkpoint Inhibitors in Cancer Treatment — April 3, 2017, Washington, DC


Submissions for this form are closed.

This activity is intended for medical oncologists, hematologists, surgeons, radiation oncologists, oncology nurses and other healthcare professionals involved in basic, translational and clinical cancer research or treatment.

Meeting Information
Meeting:

Molecular Tumor Board: Integrating Biomarker Analyses into Clinical Decision-Making Regarding the Use of Immune Checkpoint Inhibitors in Cancer Treatment

Date:

Monday, April 3, 2017

Time (Eastern Time):

6:30 PM – 7:00 PM
Registration and Buffet Dinner 7:00 PM – 9:00 PM
Educational Program

Location:

Grand Hyatt Washington
1000 H St NW
Washington, DC 20001
Hotel Phone: (202) 582-1234

Meeting Room:

Independence Ballroom A (Level 5B)

Faculty:

Johanna C Bendell, MDCharles G Drake, MD, PhDRoy S Herbst, MD, PhDDavid F McDermott, MDCraig Moskowitz, MD

Moderator:

Neil Love, MD

Thank you for your interest in our CME program. At this time online preregistration is limited to clinicians in practice. Onsite registration will be open starting at 6:15 PM (local time) on Monday, April 3, 2017. If you are interested in attending, please visit our registration desk located outside Independence Ballroom A (Level 5B) of the Grand Hyatt Washington hotel (1000 H St NW, Washington, DC 20001).


If seats become available for the program, we will accept new registrations on a first come, first served basis but with priority given to clinicians in practice. Please note, onsite registration does not guarantee participation in the session or meal service.


If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com or call (800) 233-6153.